The primary endpoint of 12-month Event Free Survival (EFS) for OST-HER2- treated patients (35%) was statistically significant (p= 0.0194) when compared with peer-reviewed comparable historical control ...

Forbes contributors publish independent expert analyses and insights. Josie Cox is a New York-based journalist covering business and gender. Feb 05, 2025, 05:08pm EST Among women aged 25 to 54, ...

Findings showed abemaciclib plus endocrine therapy statistically significantly improved OS vs endocrine therapy alone after 2 years. Topline data were announced from a phase 3 trial evaluating ...

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity on both tumor growth and cancer cell spread. In one of these animal models ...